Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
5.77
-0.35 (-5.72%)
Mar 31, 2025, 1:07 PM EDT - Market open
Ginkgo Bioworks Holdings Revenue
In the year 2024, Ginkgo Bioworks Holdings had annual revenue of $227.04M, down -9.71%. Ginkgo Bioworks Holdings had revenue of $43.85M in the quarter ending December 31, 2024, with 26.16% growth.
Revenue (ttm)
$227.04M
Revenue Growth
-9.71%
P/S Ratio
1.40
Revenue / Employee
$272,234
Employees
834
Market Cap
313.69M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
DNA News
- 4 weeks ago - Ginkgo Bioworks: Revenue Struggles Continue - Seeking Alpha
- 4 weeks ago - 2025 Is Make Or Break For Ginkgo Bioworks - Seeking Alpha
- 4 weeks ago - Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 4 weeks ago - Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 5 weeks ago - Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab - PRNewsWire
- 5 weeks ago - Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care - PRNewsWire
- 5 weeks ago - Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation - PRNewsWire